Clinical Trial Update: The Colitis Once Daily Asacol Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Colitis Once Daily Asacol study (NCT00708656) in ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Asacol (mesalamine)

Snippet

Sponsor: Cardiff and Vale University Health Board | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED